Top News

FDA building representing regulatory review of antibody drug conjugates

INNOVATION

2 Oct 2025

Cancer’s guided missiles grow up

AbbVie, Pfizer and Merck advance antibody drug conjugates through late-stage trials and regulatory filings in a shift towards precision on...

FDA Food and Drug Administration document with stethoscope

REGULATORY

12 Feb 2026

A Faster Track for Myeloma Treatments?

TECHNOLOGY

4 Feb 2026

Why Antibody Drug Design Is Becoming an AI Problem

Latest News

Is This ADC the Chemo Killer TNBC Needed?

US Food and Drug Administration outdoor campus sign with FDA and HHS seals

REGULATORY

7 May 2026

Dato-DXd nears US approval for first-line metastatic TNBC, backed by a landmark 5-month survival gain over chemotherapy

Antibody drug conjugate molecules supporting next-generation cancer therapy development

PARTNERSHIPS

23 Oct 2025

Faster or Failed? ADC Developers Rethink How Drugs Get Built

Invenra and Xcellon Biologics link discovery and manufacturing early to speed next-generation ADCs toward the clinic

INNOVATION

2 Oct 2025

Cancer’s guided missiles grow up

AbbVie, Pfizer and Merck advance antibody drug conjugates through late-stage trials and regulatory filings in a shift towards precision on...

INNOVATION

16 Sep 2025

A Regulatory Signal That Precision Cancer Care Is Maturing

FDA backing for a next-generation ADC underscores growing confidence in targeted cancer drugs and signals faster momentum across oncology ...

Molecular structure of antibody drug conjugates advancing targeted cancer care

MARKET TRENDS

10 Feb 2025

Why ADCs Are Becoming Oncology’s Most Reliable Trend

Landmark ADC deals from 2023–2024 and new 2025 approvals underscore sustained momentum in targeted cancer care

3 4

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.